Study describes factors associated with cancer-specific death for patients diagnosed with NETs

Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer was higher than that of dying of other causes, but mortality varies by primary tumor site, according to a new study published in the August 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network.